Table 4.
Mean Bilirubin peak levels and allergic outcomes.
| Allergic outcome by month 18 |
Mean Bilirubin Peak ± SD (Outcome = yes) |
Mean Bilirubin Peak ± SD (Outcome = No) |
Adjusted OR | P value |
| Allergen sensitization | 206.4 ± 54.2 | 228.6 ± 39.7 | 0.97 (0.95–0.99) | 0.02 |
| Eczema | 234.4± 36.5 | 226.7± 41.7 | 1.00 (0.99–1.02) | 0.7 |
| Rhinitis | 239.8 ± 43.2 | 226.0 ± 42.8 | 1.04 (0.99–1.1) | 0.1 |
| Wheeze and use of nebulizer | 238.3± 48.4 | 227.5 ± 40.6 | 1.02 (0.99–1.1) | 0.2 |
| Allergic outcome by month 36 |
Mean Bilirubin Peak ± SD (Outcome = yes) |
Mean Bilirubin Peak ± SD (Outcome = No) |
Adjusted OR | P value |
| Allergen sensitization | 217.8± 48.3 | 227.5± 43.0 | 0.98 (0.96–0.99) | 0.02 |
| Eczema | 235.5 ± 35.5 | 226.1 ± 42.0 | 1.0 (0.99–1.03) | 0.3 |
| Rhinitis | 234.8 ± 45.0 | 224.4 ± 41.7 | 1.0 (0.99–1.03) | 0.1 |
| Wheeze and use of nebulizer | 226.8 ± 46.3 | 227.1 ± 41.6 | 1.0 (0.98–1.02) | 0.8 |
| Allergic outcome by month 60 |
Mean Bilirubin Peak ± SD (Outcome = yes) |
Mean Bilirubin Peak ± SD (Outcome = No) |
Adjusted OR | P value |
| Allergen sensitization | 228.1 ± 45.4 | 228.6 ± 43.2 | 0.99 (0.98–1.02) | 0.7 |
| Eczema | 236.8 ± 34.9 | 225.1 ± 42.5 | 1.01 (0.99–1.03) | 0.3 |
| Rhinitis | 235.7 ± 44.0 | 222.8 ± 42.2 | 1.02 (0.99–1.04) | 0.1 |
| Wheeze and use of nebulizer | 224.9 ± 51.4 | 226.2 ± 41.0 | 0.99 (0.98–1.02) | 0.9 |
*
Adjusted for sex, ethnicity, breastfeeding levels, family history of allergy, gestational age, maternal education levels and mode of delivery